Adverse events · people with non‐transfusion‐dependent β‐thalassaemia
1 finding from 1 review
Discontinuation of medication due to adverse events · pre‐existing and new‐onset diabetes in kidney transplant recipients
1 finding from 1 review
Serious adverse events/death · rehabilitation vs less time spent
Summary of findings table ‐ More time showed no clear difference in serious adverse events/death compared with less time (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with fibromyalgia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Local adverse events: skin thinning; end of treatment (2‐5 weeks) · children and adults, most with moderate to severe eczema
1 finding from 1 review
Intervention not reported
Number of participants experiencing 1 or more serious adverse events at the end of the intervention period · cognitively healthy people in late life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of participants experiencing 1 or more serious adverse events at the end of the intervention period · cognitively healthy people in late life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Systemic adverse events: abnormal cortisol; end of treatment (1‐6 weeks) · children and adults, most with moderate to severe eczema
1 finding from 1 review
Adverse events: hypertension · children with nephrotic syndrome
Steroid therapy in first episode of nephrotic syndrome: 3 months or… showed no clear difference in adverse events: hypertension compared with 2 months of therapy (moderate certainty).
1 finding from 1 review
One or more adverse events · Patients with presumed drug‐sensitive TB
1 finding from 1 review
Adverse events: Cushing's syndrome · children with nephrotic syndrome
Steroid therapy in first episode of nephrotic syndrome: 3 months or… showed no clear difference in adverse events: Cushing's syndrome compared with 2 months of therapy (moderate certainty).
1 finding from 1 review
Serious adverse events/death: medium‐term outcomes · rehabilitation (medium‐term outcomes)
It is very uncertain whether summary of findings table ‐ More time changes serious adverse events/death: medium‐term outcomes compared with less time (very low certainty).
1 finding from 1 review
Adverse events: psychological disorders · children with nephrotic syndrome
Steroid therapy in first episode of nephrotic syndrome: 3 months or… showed no clear difference in adverse events: psychological disorders compared with 2 months of therapy (low certainty).
1 finding from 1 review
Serious adverse events/death: long‐term outcomes ‐ not reported · rehabilitation (long‐term outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (AEs) (1 or more events) · People with vascular dementia
FuFangHaiShe showed no clear difference in adverse events (AEs) (1 or more) compared with 'no treatment' (low certainty).
1 finding from 1 review
Adverse events (AEs) (1 or more events) · People with vascular dementia
FuFangDanShen showed no clear difference in adverse events (AEs) (1 or more) compared with 'no treatment' (low certainty).
1 finding from 1 review
Adverse events (AEs) (1 or more events) · People with vascular dementia
TongXingLuo showed no clear difference in adverse events (AEs) (1 or more) compared with western medicine (low certainty).
1 finding from 1 review
Intervention not reported
One or more serious adverse events · cognitively healthy people in midlife
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (AEs) (1 or more events) · People with vascular dementia
YinDanXingNaoTong showed no clear difference in adverse events (AEs) (1 or more events) compared with 'no treatment' (low certainty).
1 finding from 1 review
Adverse events (AEs) (1 or more events) · People with vascular dementia
It is very uncertain whether naoMaiTai changes adverse events (AEs) (1 or more events) compared with western medicine (very low certainty).
1 finding from 1 review